Myelination of peripheral nerve fibres is performed by Schwann cells and is
associated with the coordinate upregulation of lipid synthesis and multipl
e genes encoding myelin-specific proteins. Both the decision to enter into
a myelinating phenotype and subsequently, the quantity of myelin that each
Schwann cell elaborates appear to be controlled by axonal signals. Understa
nding of the relevant signaling pathways and the downstream transcription f
actors and cis elements that confer myelin gene expression is notably limit
ed. In large part, this has resulted direcly from a lack of methods for obt
aining nuclear extracts from myelinating Schwann cells thus precluding the
application of numerous powerful molecular techniques. In this report, we d
escribe a method that overcomes this limitation for the myelinating Schwann
cells in the sciatic nerves of the mouse. During the evolution of the meth
od, its effectiveness was monitored using an oligonucleotide containing the
binding site for KROX-20, a transcription factor known to be present in my
elinating Schwann cells. Following technical development, the optimized pro
tocol has proven to be entirely reliable and thus novel experimental strate
gies now can be applied to the investigation of the molecular mechanisms co
ntrolling gene expression in peripheral nerves. (C) 1999 Elsevier Science B
.V. All rights reserved.